A Risk Factor Analysis of SARS-CoV-2 Infection in Animals in COVID-19-Affected Households
Abstract
:1. Introduction
2. Materials and Methods
2.1. Recruiting SARS-CoV-2-Positive Households and Sampling
2.2. Sample Analysis—Nucleic Acid Extraction, Molecular Analysis, and Confirmation
2.3. Sample Analysis—Serological SARS-CoV-2 Testing
2.4. Data Acquisition via Online Questionnaire
2.5. Data Evaluation and Statistics
3. Results
3.1. Participating COVID-19-Affected Households
3.2. Detection of SARS-CoV-2 Viral RNA and Confirmation of SARS-CoV-2 Infection via Serology
3.3. Surface Samples
3.4. Statistical Evaluation of the Questionnaire
3.4.1. Univariable Logistic Regression
3.4.2. Multivariable Binary Logistic Regression
3.5. Owner Samples
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Appendix A
References
- Fritz, M.; Rosolen, B.; Krafft, E.; Becquart, P.; Elguero, E.; Vratskikh, O.; Denolly, S.; Boson, B.; Vanhomwegen, J.; Gouilh, M.A.; et al. High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households. One Health 2021, 11, 100192. [Google Scholar] [CrossRef] [PubMed]
- Hamer, S.A.; Pauvolid-Correa, A.; Zecca, I.B.; Davila, E.; Auckland, L.D.; Roundy, C.M.; Tang, W.; Torchetti, M.K.; Killian, M.L.; Jenkins-Moore, M.; et al. SARS-CoV-2 Infections and Viral Isolations among Serially Tested Cats and Dogs in Households with Infected Owners in Texas, USA. Viruses 2021, 13, 938. [Google Scholar] [CrossRef] [PubMed]
- Goryoka, G.W.; Cossaboom, C.M.; Gharpure, R.; Dawson, P.; Tansey, C.; Rossow, J.; Mrotz, V.; Rooney, J.; Torchetti, M.; Loiacono, C.M.; et al. One Health Investigation of SARS-CoV-2 Infection and Seropositivity among Pets in Households with Confirmed Human COVID-19 Cases-Utah and Wisconsin, 2020. Viruses 2021, 13, 1813. [Google Scholar] [CrossRef] [PubMed]
- da Silva Torres, M.K.; Lopes, F.T.; de Lima, A.C.R.; Lima, C.N.C.; Dos Santos Brito, W.R.; Dos Santos, B.C.; de Sousa, R.S.; Gomes, J.L.C.; Botelho, B.J.S.; Correa, A.C.A.; et al. Seroprevalence and risk factors for COVID-19 in the metropolis of the Brazilian Amazon. Sci. Rep. 2022, 12, 8571. [Google Scholar] [CrossRef] [PubMed]
- de Lusignan, S.; Dorward, J.; Correa, A.; Jones, N.; Akinyemi, O.; Amirthalingam, G.; Andrews, N.; Byford, R.; Dabrera, G.; Elliot, A.; et al. Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: A cross-sectional study. Lancet Infect. Dis. 2020, 20, 1034–1042. [Google Scholar] [CrossRef]
- Li, X.; Xia, W.Y.; Jiang, F.; Liu, D.Y.; Lei, S.Q.; Xia, Z.Y.; Wu, Q.P. Review of the risk factors for SARS-CoV-2 transmission. World J. Clin. Cases 2021, 9, 1499–1512. [Google Scholar] [CrossRef]
- Rasheed, Z.; Alhomaidan, H.; Shariq, A.; Alkhowailed, M.; Alqossayir, F.; Rasheed, N.; Alkhamiss, A.; Alghsham, R.; Hershan, A.; Alharbi, S.; et al. An Updated Analysis on the Risk Factors Associated with COVID-19 Transmission. Open Access Maced. J. Med. Sci. 2022, 10, 355–360. [Google Scholar] [CrossRef]
- Madewell, Z.J.; Yang, Y.; Longini, I.M., Jr.; Halloran, M.E.; Dean, N.E. Factors Associated with Household Transmission of SARS-CoV-2: An Updated Systematic Review and Meta-analysis. JAMA Netw. Open 2021, 4, e2122240. [Google Scholar] [CrossRef]
- Stangeland, B. How to evaluate the success of the COVID-19 measures implemented by the Norwegian government by analyzing changes in doubling time. medRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
- Cowling, B.J.; Ali, S.T.; Ng, T.W.Y.; Tsang, T.K.; Li, J.C.M.; Fong, M.W.; Liao, Q.; Kwan, M.Y.W.; Lee, S.L.; Chiu, S.S.; et al. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: An observational study. Lancet Public Health 2020, 5, e279–e288. [Google Scholar] [CrossRef]
- Cheng, Y.; Ma, N.; Witt, C.; Rapp, S.; Wild, P.S.; Andreae, M.O.; Pöschl, U.; Su, H. Face masks effectively limit the probability of SARS-CoV-2 transmission. Science 2021, 372, 1439–1443. [Google Scholar] [CrossRef]
- Xie, C.; Zhao, H.; Li, K.; Zhang, Z.; Lu, X.; Peng, H.; Wang, D.; Chen, J.; Zhang, X.; Wu, D.; et al. The evidence of indirect transmission of SARS-CoV-2 reported in Guangzhou, China. BMC Public Health 2020, 20, 1202. [Google Scholar] [CrossRef]
- Hirose, R.; Ikegaya, H.; Naito, Y.; Watanabe, N.; Yoshida, T.; Bandou, R.; Daidoji, T.; Itoh, Y.; Nakaya, T. Survival of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Virus on Human Skin: Importance of Hand Hygiene in Coronavirus Disease 2019 (COVID-19). Clin. Infect. Dis. 2021, 73, e4329–e4335. [Google Scholar] [CrossRef]
- Behzadinasab, S.; Chin, A.W.H.; Hosseini, M.; Poon, L.L.M.; Ducker, W.A. SARS-CoV-2 virus transfers to skin through contact with contaminated solids. Sci. Rep. 2021, 11, 22868. [Google Scholar] [CrossRef]
- Chin, A.W.H.; Chu, J.T.S.; Perera, M.R.A.; Hui, K.P.Y.; Yen, H.-L.; Chan, M.C.W.; Peiris, M.; Poon, L.L.M. Stability of SARS-CoV-2 in different environmental conditions. Lancet Microbe 2020, 1, e10. [Google Scholar] [CrossRef]
- Marcenac, P.; Park, G.W.; Duca, L.M.; Lewis, N.M.; Dietrich, E.A.; Barclay, L.; Tamin, A.; Harcourt, J.L.; Thornburg, N.J.; Rispens, J.; et al. Detection of SARS-CoV-2 on Surfaces in Households of Persons with COVID-19. Int. J. Environ. Res. Public Health 2021, 18, 8184. [Google Scholar] [CrossRef]
- Maestre, J.P.; Jarma, D.; Yu, J.F.; Siegel, J.A.; Horner, S.D.; Kinney, K.A. Distribution of SARS-CoV-2 RNA signal in a home with COVID-19 positive occupants. Sci. Total Environ. 2021, 778, 146201. [Google Scholar] [CrossRef]
- Bienzle, D.; Rousseau, J.; Marom, D.; MacNicol, J.; Jacobson, L.; Sparling, S.; Prystajecky, N.; Fraser, E.; Weese, J.S. Risk Factors for SARS-CoV-2 Infection and Illness in Cats and Dogs(1). Emerg. Infect. Dis. 2022, 28, 1154–1162. [Google Scholar] [CrossRef]
- Bessiere, P.; Vergne, T.; Battini, M.; Brun, J.; Averso, J.; Joly, E.; Guerin, J.L.; Cadiergues, M.C. SARS-CoV-2 Infection in Companion Animals: Prospective Serological Survey and Risk Factor Analysis in France. Viruses 2022, 14, 1178. [Google Scholar] [CrossRef]
- Klaus, J.; Meli, M.L.; Willi, B.; Nadeau, S.; Beisel, C.; Stadler, T.; Egberink, H.; Zhao, S.; Lutz, H.; Riond, B.; et al. Detection and Genome Sequencing of SARS-CoV-2 in a Domestic Cat with Respiratory Signs in Switzerland. Viruses 2021, 13, 496. [Google Scholar] [CrossRef]
- Studer, N.; Lutz, H.; Saegerman, C.; Gonczi, E.; Meli, M.L.; Boo, G.; Hartmann, K.; Hosie, M.J.; Moestl, K.; Tasker, S.; et al. Pan-European Study on the Prevalence of the Feline Leukaemia Virus Infection—Reported by the European Advisory Board on Cat Diseases (ABCD Europe). Viruses 2019, 11, 993. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gomes-Keller, M.A.; Tandon, R.; Gonczi, E.; Meli, M.L.; Hofmann-Lehmann, R.; Lutz, H. Shedding of feline leukemia virus RNA in saliva is a consistent feature in viremic cats. Vet. Microbiol. 2006, 112, 11–21. [Google Scholar] [CrossRef] [PubMed]
- Kuhlmeier, E.; Chan, T.; Agui, C.V.; Willi, B.; Wolfensberger, A.; Beisel, C.; Topolsky, I.; Beerenwinkel, N.; Stadler, T.; Swiss Sars-Co, V.S.C.; et al. Detection and Molecular Characterization of the SARS-CoV-2 Delta Variant and the Specific Immune Response in Companion Animals in Switzerland. Viruses 2023, 15, 245. [Google Scholar] [CrossRef] [PubMed]
- Klaus, J.; Zini, E.; Hartmann, K.; Egberink, H.; Kipar, A.; Bergmann, M.; Palizzotto, C.; Zhao, S.; Rossi, F.; Franco, V.; et al. SARS-CoV-2 Infection in Dogs and Cats from Southern Germany and Northern Italy during the First Wave of the COVID-19 Pandemic. Viruses 2021, 13, 1453. [Google Scholar] [CrossRef]
- Davis, C.; Logan, N.; Tyson, G.; Orton, R.; Harvey, W.T.; Perkins, J.S.; Mollett, G.; Blacow, R.M.; Consortium, C.-G.U.; Peacock, T.P.; et al. Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination. PLoS Pathog. 2021, 17, e1010022. [Google Scholar] [CrossRef]
- Dohoo, I.R.; Fourichon, C.D.C.; Donald, A.; Hurnik, D. An overview of techniques for dealing with large numbers of independent variables in epidemiologic studies. Prev. Vet. Med. 1997, 29, 221–239. [Google Scholar] [CrossRef]
- Spada, E.; Carrera Nulla, A.; Perego, R.; Baggiani, L.; Proverbio, D. Evaluation of Association between Blood Phenotypes A, B and AB and Feline Coronavirus Infection in Cats. Pathogens 2022, 11, 917. [Google Scholar] [CrossRef]
- Riemer, F.; Kuehner, K.A.; Ritz, S.; Sauter-Louis, C.; Hartmann, K. Clinical and laboratory features of cats with feline infectious peritonitis--a retrospective study of 231 confirmed cases (2000–2010). J. Feline Med. Surg. 2016, 18, 348–356. [Google Scholar] [CrossRef] [Green Version]
- Aart, A.E.; Velkers, F.C.; Fischer, E.A.J.; Broens, E.M.; Egberink, H.; Zhao, S.; Engelsma, M.; Hakze-van der Honing, R.W.; Harders, F.; Rooij, M.M.T.; et al. SARS-CoV-2 infection in cats and dogs in infected mink farms. Transbound. Emerg. Dis. 2021, 69, 3001–3007. [Google Scholar] [CrossRef]
- Fateh-Moghadam, P.; Battisti, L.; Molinaro, S.; Fontanari, S.; Dallago, G.; Binkin, N.; Zuccali, M. Contact tracing during Phase I of the COVID-19 pandemic in the Province of Trento, Italy: Key findings and recommendations. medRxiv 2020. [Google Scholar] [CrossRef]
- Dattner, I.; Goldberg, Y.; Katriel, G.; Yaari, R.; Gal, N.; Miron, Y.; Ziv, A.; Sheffer, R.; Hamo, Y.; Huppert, A. The role of children in the spread of COVID-19: Using household data from Bnei Brak, Israel, to estimate the relative susceptibility and infectivity of children. PLoS Comput. Biol. 2021, 17, e1008559. [Google Scholar] [CrossRef]
- Stull, J.W.; Peregrine, A.S.; Sargeant, J.M.; Weese, J.S. Pet husbandry and infection control practices related to zoonotic disease risks in Ontario, Canada. BMC Public Health 2013, 13, 520. [Google Scholar] [CrossRef] [Green Version]
- van Doremalen, N.; Bushmaker, T.; Morris, D.H.; Holbrook, M.G.; Gamble, A.; Williamson, B.N.; Tamin, A.; Harcourt, J.L.; Thornburg, N.J.; Gerber, S.I.; et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N. Engl. J. Med. 2020, 382, 1564–1567. [Google Scholar] [CrossRef]
- Kampf, G.; Lemmen, S.; Suchomel, M. Ct values and infectivity of SARS-CoV-2 on surfaces. Lancet Infect. Dis. 2020, 21, e141. [Google Scholar] [CrossRef]
- Virtanen, J.; Aaltonen, K.; Kivisto, I.; Sironen, T. Survival of SARS-CoV-2 on Clothing Materials. Adv. Virol. 2021, 2021, 6623409. [Google Scholar] [CrossRef]
- Ji, W.; Li, X.; Chen, S.; Ren, L. Transmission of SARS-CoV-2 via fomite, especially cold chain, should not be ignored. Proc. Natl. Acad. Sci. USA 2021, 118, e2026093118. [Google Scholar] [CrossRef]
- Pastorino, B.; Touret, F.; Gilles, M.; de Lamballerie, X.; Charrel, R.N. Prolonged Infectivity of SARS-CoV-2 in Fomites. Emerg. Infect. Dis. 2020, 26, 2256. [Google Scholar] [CrossRef]
- Goldman, E. Exaggerated risk of transmission of COVID-19 by fomites. Lancet Infect. Dis. 2020, 20, 892–893. [Google Scholar] [CrossRef]
- Lewis, D. COVID-19 rarely spreads through surfaces. So why are we still deep cleaning? Nature 2021, 590, 26–28. [Google Scholar] [CrossRef]
- Lewis, D. The challenges of making indoors safe. Nature 2021, 592, 22–25. [Google Scholar] [CrossRef]
- World Health Organization. Coronavirus Disease (COVID-19): How Is It Transmitted? Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-covid-19-how-is-it-transmitted (accessed on 27 July 2021).
- Klaus, J.; Palizzotto, C.; Zini, E.; Meli, M.L.; Leo, C.; Egberink, H.; Zhao, S.; Hofmann-Lehmann, R. SARS-CoV-2 Infection and Antibody Response in a Symptomatic Cat from Italy with Intestinal B-Cell Lymphoma. Viruses 2021, 13, 527. [Google Scholar] [CrossRef]
- Ng, W.H.; Tipih, T.; Makoah, N.A.; Vermeulen, J.G.; Goedhals, D.; Sempa, J.B.; Burt, F.J.; Taylor, A.; Mahalingam, S. Comorbidities in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis. mBio 2021, 12, e03647-20. [Google Scholar] [CrossRef] [PubMed]
- Yang, J.; Zheng, Y.; Gou, X.; Pu, K.; Chen, Z.; Guo, Q.; Ji, R.; Wang, H.; Wang, Y.; Zhou, Y. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis. Int. J. Infect. Dis. 2020, 94, 91–95. [Google Scholar] [CrossRef] [PubMed]
- Bosco-Lauth, A.M.; Hartwig, A.E.; Porter, S.M.; Gordy, P.W.; Nehring, M.; Byas, A.D.; VandeWoude, S.; Ragan, I.K.; Maison, R.M.; Bowen, R.A. Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats. Proc. Natl. Acad. Sci. USA 2020, 117, 26382–26388. [Google Scholar] [CrossRef] [PubMed]
- Barroso, R.; Vieira-Pires, A.; Antunes, A.; Fidalgo-Carvalho, I. Susceptibility of Pets to SARS-CoV-2 Infection: Lessons from a Seroepidemiologic Survey of Cats and Dogs in Portugal. Microorganisms 2022, 10, 345. [Google Scholar] [CrossRef]
- Centers for Disease Control and Prevention CDC. Symptoms of COVID-19. Available online: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html (accessed on 7 February 2023).
- Centers for Disease Control and Prevention CDC. What You Should Know about COVID-19 and Pets. Available online: https://www.cdc.gov/healthypets/covid-19/pets.html (accessed on 7 February 2023).
- Zheng, S.; Fan, J.; Yu, F.; Feng, B.; Lou, B.; Zou, Q.; Xie, G.; Lin, S.; Wang, R.; Yang, X.; et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January–March 2020: Retrospective cohort study. BMJ 2020, 369, m1443. [Google Scholar] [CrossRef] [Green Version]
- de Souza Barbosa, A.B.; Kmetiuk, L.B.; de Carvalho, O.V.; Brandao, A.P.D.; Doline, F.R.; Lopes, S.; Meira, D.A.; de Souza, E.M.; da Silva Trindade, E.; Baura, V.; et al. Infection of SARS-CoV-2 in domestic dogs associated with owner viral load. Res. Vet. Sci. 2022, 153, 61–65. [Google Scholar] [CrossRef]
- He, X.; Lau, E.H.Y.; Wu, P.; Deng, X.; Wang, J.; Hao, X.; Lau, Y.C.; Wong, J.Y.; Guan, Y.; Tan, X.; et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat. Med. 2020, 26, 672–675. [Google Scholar] [CrossRef] [Green Version]
Animal ID | Age | Pre-Existing Conditions * | Clinical Signs * | RT-qPCR Results | Serology | ||||
---|---|---|---|---|---|---|---|---|---|
Oral | Nasal | Fecal | Fur | Bed | |||||
Cat 22.2 | N/A | Not known | Unsure | + | + | N/A | + | + | + |
Cat 26.2 | 13 | No | + | - | N/A | + | + | N/A | |
Cat 29.3 | 5 | No | + | + | N/A | + | + | N/A | |
Cat 35.1 | 7 | No | Respiratory sounds | - | + | - | + | + | N/A |
Cat 36.1 | 19 | Hyperthyroidism and kidney disease | + | + | + | + | + | + | |
Cat 38.2 | N/A | Giardia (gastrointestinal) | Ocular discharge, vomiting, tiredness/listlessness, and reduced appetite | + | + | + | + | + | N/A |
Cat 39.1 Cat 39.2 | 7 13 | No No | Nasal discharge Unsure | + + | + + | - + | + + | + + | + + |
Cat 41.3 | 4 | No | - | + | - | + | + | N/A | |
Cat 43.1 Cat 43.2 Cat 43.3 Cat 43.4 Cat 43.5 Cat 43.6 Cat 43.7 Cat 43.8 Cat 43.9 | 17 9 9 5 5 3 <1 <1 <1 | No No Blindness No No No No No No | + + - + + + + + - | + + - + + + + + - | + + + + + + + + + | + + + + + + + + + | + + + + + + + + + | N/A N/A N/A N/A N/A N/A N/A N/A N/A | |
Cat 47.2 | 6 | No | - | + | - | + | + | N/A | |
Cat 49.1 Cat 49.2 | 11 17 | Not known Not known | - + | - - | + + | + + | + + | + + | |
Cat 50.1 | 1 | No | + | + | - | + | + | N/A | |
Cat 53.1 | 12 | No | - | - | + | + | + | N/A | |
Cat 55.1 | 5 | No | - | + | N/A | + | + | N/A | |
Cat 67.1 | 10 | No | Vomiting | - | + | - | - | - | N/A |
Cat 68.2 | 2 | No | - | - | + | + | + | N/A | |
Cat 106.1 Cat 106.2 | 5 5 | No No | - - | + + | + + | + + | + + | - - | |
Cat 140.1 | 10 | No | Vomiting | - | + | + | + | + | N/A |
Cat 152.1 | 5 | No | - | + | N/A | + | + | - | |
Cat 154.2 | 2 | No | - | - | + | + | + | N/A | |
Cat 169.2 | <1 | Eye infection | + | - | - | + | + | N/A | |
Cat 174.1 Cat 174.2 | N/A N/A | No No | N/A N/A | N/A N/A | N/A N/A | N/A N/A | N/A N/A | + + | |
Cat 179.1 | 5 | No | + | - | - | + | + | N/A | |
Cat 159.1.1 Cat 159.1.5 | 12 2 | Degenerative changes No | + - | - + | + + | + + | + + | N/A N/A | |
Total | 5 | 5 | 19 | 24 | 22 | 34 | 34 | 8 |
Animal ID | Age | Pre-Existing * Conditions | Clinical Signs * | RT-qPCR Results | Serology | ||||
---|---|---|---|---|---|---|---|---|---|
Oral | Nasal | Fecal | Fur | Bed | |||||
Dog 22.1 | N/A | Unknown | Unsure | + | + | - | + | + | + |
Dog 29.1 | <1 | Pneumonia | Tiredness/listlessness | + | + | + | + | + | + |
Dog 32.1 | 14 | Renal insufficiency | Diarrhea (unsure) | - | + | - | + | + | N/A |
Dog 37.1 | 9 | Borreliosis | Tiredness/listlessness | + | + | - | + | + | N/A |
Dog 71.1 Dog 71.2 | 5 <1 | No No | + - | - + | - + | + + | + + | N/A N/A | |
Dog 79.1 | 5 | No | - | + | - | + | + | - | |
Dog 87.1 | <1 | No | - | - | + | + | + | N/A | |
Dog 127.1 | 4 | No | - | + | - | + | + | - | |
Dog 156.1 | 11 | Unknown | Respiratory sounds, ocular discharge | - | - | + | + | + | - |
Dog 159.1.6 Dog 159.1.7 | 7 3 | No Eosinophilic bronchopathy | - - | + - | + + | + + | + + | - - | |
Total | 4 | 4 | 4 | 8 | 6 | 12 | 12 | 2 |
Variables HOUSEHOLDS | Modalities | All Households (122 Households) 1 | Households with Negative-Tested Animals (91) | Households with Positive-Tested Animals (31) | Univariable Regression |
Number of positive household members | 1 >1 | 55 67 | 46 (37.7%) 45 (36.9%) | 9 (7.4%) 22 (18.0%) | 0.041 |
Minors in the household | No Yes | 75 47 | 62 (50.8%) 29 (23.8%) | 13 (10.7%) 18 (14.7%) | 0.011 |
Variables HOUSEHOLD- MEMBERS | Modalities | All household members (336 people) | Household members from households with negative-tested animals (241) | Household members from households with positive-tested animals (95) | Univariable regression |
Contact time of the household members with the animals | <10 min a day 10 min–2 h a day 2–8 h a day >8 h a day | 16 150 110 58 | 13 (3.9%) 96 (28.7%) 83 (24.8%) 47 (14.1%) | 3 (0.9%) 54 (16.2%) 27 (8.1%) 11 (3.3%) | 0.043 |
Handwashing with soap | ≤4 times/day 5–6 times/day ≥7 times/day | 94 104 125 | 65 (20.1%) 68 (21.1%) 97 (30.0%) | 29 (9.0%) 36 (11.1%) 28 (8.7%) | 0.113 |
Variables CATS | Modalities | All cats (172 cats) | SARS-CoV-2-negative cats (135) | SARS-CoV-2-positive cats (37) | Univariable regression |
Outdoor access | Exclusively in the flat Access to balcony/terrace or <2 h/day ≥2 h per day outside | 19 90 63 | 15 (8.7%) 63 (36.6%) 57 (33.2%) | 4 (2.3%) 27 (15.7%) 6 (3.5%) | 0.015 |
Licking hands | Never/rarely Often (daily)/very often (several times a day) | 116 54 | 97 (57.0%) 36 (21.2%) | 19 (11.2%) 18 (10.6%) | 0.015 |
Licking face | Never/rarely Often (daily)/very often (several times a day) | 152 18 | 126 (74.1%) 7 (4.1%) | 26 (15.3%) 11 (6.5%) | <0.001 |
Receiving treats | Never/rarely Often (daily)/very often (several times a day) | 71 97 | 50 (29.8%) 83 (49.4%) | 21 (12.5%) 14 (8.3%) | 0.019 |
Receiving food * | 1–2x daily >2x daily | 98 62 | 83 (51.9%) 43 (26.9%) | 15 (9.4%) 19 (11.8%) | 0.023 |
Removing droppings of the cat (garden/litterbox) | ≤2x daily >2x daily | 144 24 | 123 (73.2%) 9 (5.4%) | 21 (12.5%) 15 (8.9%) | <0.001 |
Cleaning litterbox (e.g., changing sand, washing, and disinfecting) | <1x per week 1x per week >1x per week | 87 39 33 | 73 (45.9%) 27 (17.0%) 27 (17.0%) | 14 (8.8%) 12 (7.5%) 6 (3.7%) | 0.166 |
Variables DOGS | Modalities | All dogs (49 dogs) | SARS-CoV-2-negative dogs (37) | SARS-CoV-2-positive dogs (12) | Univariable regression |
Pre-existing conditions | Yes No | 8 34 | 4 (9.5%) 28 (66.7%) | 4 (9.5%) 6 (14.3%) | 0.066 |
Receiving kisses | Never/rarely Often (daily)/very often | 31 18 | 21 (42.9%) 16 (32.6%) | 10 (20.4%) 2 (4.1%) | 0.112 |
Receiving food * | 1-2x daily Over 2x daily | 29 19 | 25 (52.1%) 12 (25.0%) | 4 (8.3%) 7 (14.6%) | 0.072 |
Variables | Modalities | Odds Ratio (OR) | p-Value | 95% Confidence Interval for OR |
---|---|---|---|---|
Household | ||||
Number of positive Household members | 1 >1 | - 2.326 | - 0.065 | Reference (0.948–5.707) |
Minors in the household | No Yes | - 2.795 | - 0.018 | Reference (1.192–6.552) |
Household members | ||||
Contact time of the household members with the animals | Under 10 min a day 10 min–2 h a day 2–8 h a day Over 8 h a day | - 2.521 1.523 1.088 | - 0.165 0.537 0.908 | Reference (0.682–9.313) (0.401–5.790) (0.261–4.535) |
Handwashing with soap | ≤4 times/day 5–6 times/day ≥7 times/day | - 1.227 0.684 | - 0.509 0.227 | - (0.669–2.248) (0.369–1.267) |
Cats | ||||
Outdoor access | Exclusively in the flat Access to balcony/terrace or outside <2 h/day ≥2 h | - 0.494 0.172 | - 0.331 0.045 | Reference (0.119–2.046) (0.031–0.964) |
Licking hands | Never/rarely Often (daily)/very often (several times a day) | - 0.973 | - 0.968 | Reference (0.265–3.581) |
Licking face | Never/rarely Often (daily)/very often (several times a day) | - 2.385 | - 0.336 | Reference (0.405–14.039) |
Receiving treats | Never/rarely Often (daily)/very often (several times a day) | - 0.446 | - 0.114 | Reference (0.164–1.213) |
Receiving food | 1–2x daily Over 2x daily | - 1.582 | - 0.413 | Reference (0.527–4.748) |
Removing droppings of the cat (garden/litterbox) | ≤2x daily >2x daily | - 6.056 | - 0.007 | Reference (1.639–22.373) |
Cleaning litterbox (e.g., changing sand, washing, and disinfecting) | <1x per week 1x per week >1x per week | - 0.834 0.576 | - 0.772 0.428 | Reference (0.244–2.851) (0.147–2.257) |
Dogs | ||||
Pre-existing conditions | No Yes | - 3.488 | - 0.212 | Reference (0.491–24.776) |
Receiving kisses | Never/rarely Often (daily)/very often | - 0.179 | - 0.131 | Reference (0.19–1.673) |
Receiving food | 1–2x daily Over 2x daily | - 3.378 | - 0.153 | Reference (0.637–17.920) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kuhlmeier, E.; Chan, T.; Meli, M.L.; Willi, B.; Wolfensberger, A.; Reitt, K.; Hüttl, J.; Jones, S.; Tyson, G.; Hosie, M.J.; et al. A Risk Factor Analysis of SARS-CoV-2 Infection in Animals in COVID-19-Affected Households. Viruses 2023, 15, 731. https://doi.org/10.3390/v15030731
Kuhlmeier E, Chan T, Meli ML, Willi B, Wolfensberger A, Reitt K, Hüttl J, Jones S, Tyson G, Hosie MJ, et al. A Risk Factor Analysis of SARS-CoV-2 Infection in Animals in COVID-19-Affected Households. Viruses. 2023; 15(3):731. https://doi.org/10.3390/v15030731
Chicago/Turabian StyleKuhlmeier, Evelyn, Tatjana Chan, Marina L. Meli, Barbara Willi, Aline Wolfensberger, Katja Reitt, Julia Hüttl, Sarah Jones, Grace Tyson, Margaret J. Hosie, and et al. 2023. "A Risk Factor Analysis of SARS-CoV-2 Infection in Animals in COVID-19-Affected Households" Viruses 15, no. 3: 731. https://doi.org/10.3390/v15030731
APA StyleKuhlmeier, E., Chan, T., Meli, M. L., Willi, B., Wolfensberger, A., Reitt, K., Hüttl, J., Jones, S., Tyson, G., Hosie, M. J., Zablotski, Y., & Hofmann-Lehmann, R. (2023). A Risk Factor Analysis of SARS-CoV-2 Infection in Animals in COVID-19-Affected Households. Viruses, 15(3), 731. https://doi.org/10.3390/v15030731